Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Urinary Bladder Neoplasms 4Recurrence 1Non-Muscle Invasive Bladder Neoplasms 1

Interventions

Cyclophosphamide 3155Cisplatin 3151Carboplatin 2929Paclitaxel 2671Radiotherapy 2643Gemcitabine 2544pembrolizumab 2324Docetaxel 2154Bevacizumab 2126Fluorouracil 1819Capecitabine 1780Oxaliplatin 1709Dexamethasone 1589Nivolumab 1516Doxorubicin 1477Rituximab 1453Etoposide 1341Magnetic Resonance Spectroscopy 1261Irinotecan 1232Leucovorin 1212Cytarabine 1123Pemetrexed 1060Drug Therapy 1060fludarabine 1044Vincristine 956Specimen Handling 928Prednisone 924Cetuximab 919Lenalidomide 916Trastuzumab 897

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × BCG Connaught × Clear all
NCT01697306 2025-01-30

The Impact of Intravesical Gemcitabine and 1/3 Dose Bacillus Calmette-Guerin on the Quality of Life in Superficial Bladder Cancer

A.O.U. Città della Salute e della Scienza

Phase 2 Completed
120 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02948543 2023-06-18

BCG+MM

University of Sydney

Phase 3 Unknown
501 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT03664869 2021-04-01

FB10

Turku University Hospital

Phase 3 Unknown
300 enrolled
Genitourinary

Urinary Bladder Neoplasms, Recurrence

NCT01442519 2011-09-28

BCG/EMDA-MMC

University of Rome Tor Vergata

Phase 3 Completed
212 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡